Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1374985 | Bioorganic & Medicinal Chemistry Letters | 2008 | 5 Pages |
Abstract
A series of dual OX1R/OX2R orexin antagonists was prepared based on a N-glycine-sulfonamide core. SAR studies of a screening hit led to compounds with low nanomolar affinity for both receptors and good oral bioavailability. One of these compounds, 47, has demonstrated in vivo activity in rats following oral administration.
Graphical abstractThe structure–activity relationship and the synthesis of novel N-glycine-sulfonamides as OX1R/OX2R dual orexin antagonists are described. Compound 47 exhibited good oral bioavailability and has demonstrated in vivo activity in rats following oral administration.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Hamed Aissaoui, Ralf Koberstein, Cornelia Zumbrunn, John Gatfield, Catherine Brisbare-Roch, Francois Jenck, Alexander Treiber, Christoph Boss,